Skip to content

Dr Ponchon

Active
Private limited companyfounded 2013active for 13 yearsZonienboslaan 39, 3090 Overijse, BelgiumKBO/BCE: BE 0502.588.870
Summary

Dr Ponchon has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €296,807 and a net result of €110,605. Equity has been growing by about 8.1% per year since 2018. Its solvency ranks better than 26% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 18-01-2013 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment units
2.216.177.806 3090 Overijse, since 16-01-2013
2.263.825.788 1040 Etterbeek, since 01-03-2017
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€243,452
▲ 14.0%
Turnover
≈ €450,000
estimated
Profit
€110,605
▲ 36.3%
Equity
€296,807
▲ 35.5%
Total assets
€956,938
▼ 0.6%
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €956,938Figures for financial year 2025 (filed on 29-04-2026)Liquidity: current ratio 1.51, cash €248,987Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 43% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 56+8
equity 31.0% of total assets
Liquidity 77+6
short-term debt 19.5% · cash 26.0%
Profitability 69+4
return on assets 11.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025highest value 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.51 (1.2 in 2024), above the usual 1.5. Short-term debt is 19.5% and cash 26% of total assets. However, 69% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 27% of them on solvency, 58% on liquidity, 13% on profitability and 74% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €956,938
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 29-04-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.51, cash €248,987
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-04-2026, 99 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
99 days early
2024
147 days early
2023
99 days early
2022
25 days early
2021
3 days late
2020
145 days early
2019
49 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 66 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 April (4 of the last 5 accounts filed within 73 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Larger balance sheet than 86% of companies in human healthsector median €276,956 · 20,716 companies €956,938 View
  • Positive: Equity rose in 2025from €218,997 to €296,807 ▲ 35.5% View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Change of role: PONCHON Frédérique, from manager to directorPermanent representative: PONCHON Frédérique
  2. · Gazette deed Incorporation
All 18 events

Comparable companies

These companies have the same main activity as Dr Ponchon: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €825,000 and €983,000, founded between 2011 and 2013.

CompanyTotal assetsGross margin
Dr Ponchon Overijse€956,938€243,452
Traversalgo Overijse€956,218€247,825
Dr. Johan Debeuf Rotselaar€982,597€251,004
SOCIETE DE MEDECINE KADOU JOE Wezembeek-Oppem€912,626€249,415
Orthodontie Hilde Joachum Lubbeek€963,490€229,399
Dr. Sylvie GORDTS Leuven€890,698€254,956
Olivier Barket Wemmel€825,285€233,401
Full comparison

Key facts about Dr Ponchon

What is the company number of Dr Ponchon?
The company number of Dr Ponchon is 0502.588.870. The VAT number is the same number with BE in front: BE 0502.588.870.
Where is Dr Ponchon based?
The registered office is at Zonienboslaan 39, 3090 Overijse.Company details
What does Dr Ponchon do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr Ponchon?
The legal form of Dr Ponchon is Private limited company (BV).
When was Dr Ponchon founded?
Dr Ponchon was founded on 18-01-2013.
Is Dr Ponchon still active?
Yes, Dr Ponchon is an active enterprise in the KBO register.
What is the turnover of Dr Ponchon?
The turnover in financial year 2025 is ≈ €450,000. This figure is estimated from the gross margin of €243,452 and 42 comparable companies (NACE 86220). It probably lies between €380,000 and €590,000.Financials
Is Dr Ponchon profitable?
In financial year 2025, Dr Ponchon made a profit of €110,605.
Where can I find the annual accounts of Dr Ponchon?
Dr Ponchon filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr Ponchon due?
Dr Ponchon must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.